Quantinuum Targets $1.05B IPO at $45–$50 Per Share, Valuing Company at $12.7B
MS•Quantinuum plans to sell 21 million shares at $45–$50 apiece in its US IPO, targeting $1.05 billion and implying a $12.7 billion valuation at the top range. The quantum computing firm reported a $136.6 million net loss on $5.2 million revenue for the quarter ended March 31, versus a $30.5 million loss on $19.1 million revenue a year earlier.
1. IPO Structure and Valuation
Quantinuum is offering 21 million shares priced between $45 and $50 each in its initial public offering, aiming to raise $1.05 billion and secure a market valuation of $12.7 billion at the top of the range.
2. Financial Performance
For the three months ended March 31, Quantinuum posted a net loss of $136.6 million on revenue of $5.2 million, compared with a $30.5 million loss on $19.1 million revenue during the same period last year.
3. Quantum Computing Platforms
The company develops advanced quantum computers designed for chemistry, machine learning, cybersecurity, finance and drug discovery, and counts Amgen and Mitsui as early collaborators.
4. Government Support
Quantinuum is set to receive $100 million from a federal quantum computing initiative, part of over $2 billion allocated to research and development in the sector.
